Hilden, Ida <br/><br/>
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.  [electronic resource] 

 -  Blood  Jun 2012 
 - 5871-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2012-01-401620  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Blocking--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antibodies, Neutralizing--pharmacology<br/>Bleeding Time<br/>Blood Coagulation--drug effects<br/>Cross Reactions--drug effects<br/>Disease Models, Animal<br/>Epitopes--immunology<br/>Factor VIII--pharmacology<br/>Factor Xa--immunology<br/>Female<br/>Fibrin--metabolism<br/>HEK293 Cells<br/>Hemophilia A--blood<br/>Hemostasis--drug effects<br/>Human Umbilical Vein Endothelial Cells<br/>Humans<br/>Lipoproteins--metabolism<br/>Models, Molecular<br/>Neutralization Tests<br/>Protein Binding--drug effects<br/>Protein Structure, Tertiary<br/>Rabbits<br/>Species Specificity<br/>Thromboplastin--pharmacology